SURG TODAY 润色咨询

SURGERY TODAY

出版年份:1992 年文章数:2497 投稿命中率: 开通期刊会员,数据随心看

出版周期:Monthly 自引率:31.1% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2090464, encodeId=053d2090464d6, content=体验不好,投了俩月多一直处于“Awaiting Reviewer Selection”,催稿无效,无奈撤稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erSFQMYTdHQEOAxjP3M9ByU7L9UO3NIuytMKlDZxgZIIhESgLN3yeoJWWxN0fSHVtNRM0lc7o1NGQ/132, createdBy=06932512300, createdName=今天也要好好学医, createdTime=Mon Sep 26 16:34:56 CST 2022, time=2022-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944931, encodeId=bfa794493124, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享:直肠癌相关,还是比较好中的,2021-01-06投的,2021-02-02一审意见回来,2021-02-21回稿,2021-03-02接收<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=336, replyNumber=1, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1b12571876, createdName=977872291_67259390, createdTime=Tue Mar 02 21:39:24 CST 2021, time=2021-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590992, encodeId=1685590992c6, content=open access能不选择吗?版面费多少钱 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9ff42573765, createdName=门童, createdTime=Sat May 16 00:00:00 CST 2020, time=2020-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575358, encodeId=eaed5e535807, content=接受case report吗<span class="quote">博学载医 2018-02-28 发表::<br>研究方向:Surgery;; 接收率:约25% 审稿时间:约2个月 投稿一周分配编辑,一周后找到审稿人,两周后审稿结束,decision两周,还是悲剧了。两个审稿人一位没意见,另一位小意见,但是还是被拒。后来仔细看发现编辑又审了一遍,但给的意见也是major comments and minor comments,感觉主编并不友好。</span><span class="quote">博学载医 2018-02-28 17:22:00 发表:<br>投稿一周分配编辑,一周后找到审稿人,两周后审稿结束,decision两周,还是悲剧了。两个审稿人一位没意见,另一位小意见,但是还是被拒。后来仔细看发现编辑又审了一遍,但给的意见也是major comments and minor comments,感觉主编并不友好。</span>, beContent=博学载医 2018-02-28 发表:: 研究方向:Surgery;; 接收率:约25% 审稿时间:约2个月 投稿一周分配编辑,一周后找到审稿人,两周后审稿结束,decision两周,还是悲剧了。两个审稿人一位没意见,另一位小意见,但是还是被拒。后来仔细看发现编辑又审了一遍,但给的意见也是major comments and minor comments,感觉主编并不友好。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6aca5170385, createdName=146d61a5m67暂无昵称, createdTime=Mon Aug 26 00:00:00 CST 2019, time=2019-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553307, encodeId=ed4355330eb8, content=版面费有吗?<span class="quote">156HyHB2616(暂无昵称) 2017-10-25 18:14:00 发表:<br>非常靠谱的杂志.没觉得有什么偏见...一审只用了10天.大修我改了1个多月.发过去.二审8天.小修.最后投过去.接受.稿费0.免费润色</span>, beContent=156HyHB2616(暂无昵称) 2017-10-25 18:14:00 发表: 非常靠谱的杂志.没觉得有什么偏见...一审只用了10天.大修我改了1个多月.发过去.二审8天.小修.最后投过去.接受.稿费0.免费润色, objectType=tool_impact_factor, channel=null, level=null, likeNumber=313, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20180212/IMG5A81B482ECD353220.jpg, createdBy=a0c02270586, createdName=121a3a14m76(暂无昵称), createdTime=Mon Mar 05 00:00:00 CST 2018, time=2018-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553109, encodeId=4a0055310909, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:投稿一周分配编辑,一周后找到审稿人,两周后审稿结束,decision两周,还是悲剧了。两个审稿人一位没意见,另一位小意见,但是还是被拒。后来仔细看发现编辑又审了一遍,但给的意见也是major comments and minor comments,感觉主编并不友好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=338, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5b551640992, createdName=博学载医, createdTime=Wed Feb 28 17:22:00 CST 2018, time=2018-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548580, encodeId=8fab54858072, content=审稿速度:1.0<br>经验分享:非常靠谱的杂志,没觉得有什么偏见。。。一审只用了10天,大修我改了1个多月,发过去,二审8天,小修,最后投过去,接受,稿费0,免费润色, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=346, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d5ef2181269, createdName=12072d6bm16(暂无昵称), createdTime=Wed Oct 25 18:14:00 CST 2017, time=2017-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=542236, encodeId=f2a154223664, content=从1.5分以下,现在接近2分,是好现象,这个杂志是你值得拥有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=332, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qiqi, createdTime=Fri Jul 14 18:48:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=516481, encodeId=4d5051648117, content=这个杂志真的是对中国人有偏见!5月19号投的,两个月后还没有选好审稿人,中间催稿两次都说叫等!等了四个月还是没有选好审稿人,更别说送外审了!最终撤稿,并投了一个三分多的杂志,顺利接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=456, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=10e649966, createdName=xbkld007, createdTime=Sun Nov 01 17:56:00 CST 2015, time=2015-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=503113, encodeId=ec125031132b, content=老板也是日本的知名教授,更是surgery today的associated editor, 一篇大作被老板要求投到这个杂志,很不情愿的投了,谁知最后被拒稿。老板对我说很SORRY, 很无奈。我之后转投近四分杂志,不到一月,直接接收。建议大家不要投这个杂志,不要自找没趣。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=479, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri May 23 14:01:00 CST 2014, time=2014-05-23, status=1, ipAttribution=)]
    2022-09-26 今天也要好好学医

    体验不好,投了俩月多一直处于“Awaiting Reviewer Selection”,催稿无效,无奈撤稿。

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2090464, encodeId=053d2090464d6, content=体验不好,投了俩月多一直处于“Awaiting Reviewer Selection”,催稿无效,无奈撤稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erSFQMYTdHQEOAxjP3M9ByU7L9UO3NIuytMKlDZxgZIIhESgLN3yeoJWWxN0fSHVtNRM0lc7o1NGQ/132, createdBy=06932512300, createdName=今天也要好好学医, createdTime=Mon Sep 26 16:34:56 CST 2022, time=2022-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944931, encodeId=bfa794493124, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享:直肠癌相关,还是比较好中的,2021-01-06投的,2021-02-02一审意见回来,2021-02-21回稿,2021-03-02接收<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=336, replyNumber=1, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1b12571876, createdName=977872291_67259390, createdTime=Tue Mar 02 21:39:24 CST 2021, time=2021-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590992, encodeId=1685590992c6, content=open access能不选择吗?版面费多少钱 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9ff42573765, createdName=门童, createdTime=Sat May 16 00:00:00 CST 2020, time=2020-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575358, encodeId=eaed5e535807, content=接受case report吗<span class="quote">博学载医 2018-02-28 发表::<br>研究方向:Surgery;; 接收率:约25% 审稿时间:约2个月 投稿一周分配编辑,一周后找到审稿人,两周后审稿结束,decision两周,还是悲剧了。两个审稿人一位没意见,另一位小意见,但是还是被拒。后来仔细看发现编辑又审了一遍,但给的意见也是major comments and minor comments,感觉主编并不友好。</span><span class="quote">博学载医 2018-02-28 17:22:00 发表:<br>投稿一周分配编辑,一周后找到审稿人,两周后审稿结束,decision两周,还是悲剧了。两个审稿人一位没意见,另一位小意见,但是还是被拒。后来仔细看发现编辑又审了一遍,但给的意见也是major comments and minor comments,感觉主编并不友好。</span>, beContent=博学载医 2018-02-28 发表:: 研究方向:Surgery;; 接收率:约25% 审稿时间:约2个月 投稿一周分配编辑,一周后找到审稿人,两周后审稿结束,decision两周,还是悲剧了。两个审稿人一位没意见,另一位小意见,但是还是被拒。后来仔细看发现编辑又审了一遍,但给的意见也是major comments and minor comments,感觉主编并不友好。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6aca5170385, createdName=146d61a5m67暂无昵称, createdTime=Mon Aug 26 00:00:00 CST 2019, time=2019-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553307, encodeId=ed4355330eb8, content=版面费有吗?<span class="quote">156HyHB2616(暂无昵称) 2017-10-25 18:14:00 发表:<br>非常靠谱的杂志.没觉得有什么偏见...一审只用了10天.大修我改了1个多月.发过去.二审8天.小修.最后投过去.接受.稿费0.免费润色</span>, beContent=156HyHB2616(暂无昵称) 2017-10-25 18:14:00 发表: 非常靠谱的杂志.没觉得有什么偏见...一审只用了10天.大修我改了1个多月.发过去.二审8天.小修.最后投过去.接受.稿费0.免费润色, objectType=tool_impact_factor, channel=null, level=null, likeNumber=313, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20180212/IMG5A81B482ECD353220.jpg, createdBy=a0c02270586, createdName=121a3a14m76(暂无昵称), createdTime=Mon Mar 05 00:00:00 CST 2018, time=2018-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553109, encodeId=4a0055310909, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:投稿一周分配编辑,一周后找到审稿人,两周后审稿结束,decision两周,还是悲剧了。两个审稿人一位没意见,另一位小意见,但是还是被拒。后来仔细看发现编辑又审了一遍,但给的意见也是major comments and minor comments,感觉主编并不友好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=338, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5b551640992, createdName=博学载医, createdTime=Wed Feb 28 17:22:00 CST 2018, time=2018-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548580, encodeId=8fab54858072, content=审稿速度:1.0<br>经验分享:非常靠谱的杂志,没觉得有什么偏见。。。一审只用了10天,大修我改了1个多月,发过去,二审8天,小修,最后投过去,接受,稿费0,免费润色, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=346, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d5ef2181269, createdName=12072d6bm16(暂无昵称), createdTime=Wed Oct 25 18:14:00 CST 2017, time=2017-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=542236, encodeId=f2a154223664, content=从1.5分以下,现在接近2分,是好现象,这个杂志是你值得拥有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=332, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qiqi, createdTime=Fri Jul 14 18:48:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=516481, encodeId=4d5051648117, content=这个杂志真的是对中国人有偏见!5月19号投的,两个月后还没有选好审稿人,中间催稿两次都说叫等!等了四个月还是没有选好审稿人,更别说送外审了!最终撤稿,并投了一个三分多的杂志,顺利接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=456, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=10e649966, createdName=xbkld007, createdTime=Sun Nov 01 17:56:00 CST 2015, time=2015-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=503113, encodeId=ec125031132b, content=老板也是日本的知名教授,更是surgery today的associated editor, 一篇大作被老板要求投到这个杂志,很不情愿的投了,谁知最后被拒稿。老板对我说很SORRY, 很无奈。我之后转投近四分杂志,不到一月,直接接收。建议大家不要投这个杂志,不要自找没趣。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=479, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri May 23 14:01:00 CST 2014, time=2014-05-23, status=1, ipAttribution=)]
    2021-03-02 977872291_67259390

    审稿速度:1.0 | 投稿命中率:75.0
    经验分享:直肠癌相关,还是比较好中的,2021-01-06投的,2021-02-02一审意见回来,2021-02-21回稿,2021-03-02接收#肿瘤#

    1

    展开1条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2090464, encodeId=053d2090464d6, content=体验不好,投了俩月多一直处于“Awaiting Reviewer Selection”,催稿无效,无奈撤稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erSFQMYTdHQEOAxjP3M9ByU7L9UO3NIuytMKlDZxgZIIhESgLN3yeoJWWxN0fSHVtNRM0lc7o1NGQ/132, createdBy=06932512300, createdName=今天也要好好学医, createdTime=Mon Sep 26 16:34:56 CST 2022, time=2022-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944931, encodeId=bfa794493124, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享:直肠癌相关,还是比较好中的,2021-01-06投的,2021-02-02一审意见回来,2021-02-21回稿,2021-03-02接收<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=336, replyNumber=1, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1b12571876, createdName=977872291_67259390, createdTime=Tue Mar 02 21:39:24 CST 2021, time=2021-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590992, encodeId=1685590992c6, content=open access能不选择吗?版面费多少钱 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9ff42573765, createdName=门童, createdTime=Sat May 16 00:00:00 CST 2020, time=2020-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575358, encodeId=eaed5e535807, content=接受case report吗<span class="quote">博学载医 2018-02-28 发表::<br>研究方向:Surgery;; 接收率:约25% 审稿时间:约2个月 投稿一周分配编辑,一周后找到审稿人,两周后审稿结束,decision两周,还是悲剧了。两个审稿人一位没意见,另一位小意见,但是还是被拒。后来仔细看发现编辑又审了一遍,但给的意见也是major comments and minor comments,感觉主编并不友好。</span><span class="quote">博学载医 2018-02-28 17:22:00 发表:<br>投稿一周分配编辑,一周后找到审稿人,两周后审稿结束,decision两周,还是悲剧了。两个审稿人一位没意见,另一位小意见,但是还是被拒。后来仔细看发现编辑又审了一遍,但给的意见也是major comments and minor comments,感觉主编并不友好。</span>, beContent=博学载医 2018-02-28 发表:: 研究方向:Surgery;; 接收率:约25% 审稿时间:约2个月 投稿一周分配编辑,一周后找到审稿人,两周后审稿结束,decision两周,还是悲剧了。两个审稿人一位没意见,另一位小意见,但是还是被拒。后来仔细看发现编辑又审了一遍,但给的意见也是major comments and minor comments,感觉主编并不友好。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6aca5170385, createdName=146d61a5m67暂无昵称, createdTime=Mon Aug 26 00:00:00 CST 2019, time=2019-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553307, encodeId=ed4355330eb8, content=版面费有吗?<span class="quote">156HyHB2616(暂无昵称) 2017-10-25 18:14:00 发表:<br>非常靠谱的杂志.没觉得有什么偏见...一审只用了10天.大修我改了1个多月.发过去.二审8天.小修.最后投过去.接受.稿费0.免费润色</span>, beContent=156HyHB2616(暂无昵称) 2017-10-25 18:14:00 发表: 非常靠谱的杂志.没觉得有什么偏见...一审只用了10天.大修我改了1个多月.发过去.二审8天.小修.最后投过去.接受.稿费0.免费润色, objectType=tool_impact_factor, channel=null, level=null, likeNumber=313, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20180212/IMG5A81B482ECD353220.jpg, createdBy=a0c02270586, createdName=121a3a14m76(暂无昵称), createdTime=Mon Mar 05 00:00:00 CST 2018, time=2018-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553109, encodeId=4a0055310909, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:投稿一周分配编辑,一周后找到审稿人,两周后审稿结束,decision两周,还是悲剧了。两个审稿人一位没意见,另一位小意见,但是还是被拒。后来仔细看发现编辑又审了一遍,但给的意见也是major comments and minor comments,感觉主编并不友好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=338, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5b551640992, createdName=博学载医, createdTime=Wed Feb 28 17:22:00 CST 2018, time=2018-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548580, encodeId=8fab54858072, content=审稿速度:1.0<br>经验分享:非常靠谱的杂志,没觉得有什么偏见。。。一审只用了10天,大修我改了1个多月,发过去,二审8天,小修,最后投过去,接受,稿费0,免费润色, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=346, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d5ef2181269, createdName=12072d6bm16(暂无昵称), createdTime=Wed Oct 25 18:14:00 CST 2017, time=2017-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=542236, encodeId=f2a154223664, content=从1.5分以下,现在接近2分,是好现象,这个杂志是你值得拥有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=332, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qiqi, createdTime=Fri Jul 14 18:48:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=516481, encodeId=4d5051648117, content=这个杂志真的是对中国人有偏见!5月19号投的,两个月后还没有选好审稿人,中间催稿两次都说叫等!等了四个月还是没有选好审稿人,更别说送外审了!最终撤稿,并投了一个三分多的杂志,顺利接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=456, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=10e649966, createdName=xbkld007, createdTime=Sun Nov 01 17:56:00 CST 2015, time=2015-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=503113, encodeId=ec125031132b, content=老板也是日本的知名教授,更是surgery today的associated editor, 一篇大作被老板要求投到这个杂志,很不情愿的投了,谁知最后被拒稿。老板对我说很SORRY, 很无奈。我之后转投近四分杂志,不到一月,直接接收。建议大家不要投这个杂志,不要自找没趣。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=479, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri May 23 14:01:00 CST 2014, time=2014-05-23, status=1, ipAttribution=)]
    2020-05-16 门童

    open access能不选择吗?版面费多少钱

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2090464, encodeId=053d2090464d6, content=体验不好,投了俩月多一直处于“Awaiting Reviewer Selection”,催稿无效,无奈撤稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erSFQMYTdHQEOAxjP3M9ByU7L9UO3NIuytMKlDZxgZIIhESgLN3yeoJWWxN0fSHVtNRM0lc7o1NGQ/132, createdBy=06932512300, createdName=今天也要好好学医, createdTime=Mon Sep 26 16:34:56 CST 2022, time=2022-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944931, encodeId=bfa794493124, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享:直肠癌相关,还是比较好中的,2021-01-06投的,2021-02-02一审意见回来,2021-02-21回稿,2021-03-02接收<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=336, replyNumber=1, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1b12571876, createdName=977872291_67259390, createdTime=Tue Mar 02 21:39:24 CST 2021, time=2021-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590992, encodeId=1685590992c6, content=open access能不选择吗?版面费多少钱 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9ff42573765, createdName=门童, createdTime=Sat May 16 00:00:00 CST 2020, time=2020-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575358, encodeId=eaed5e535807, content=接受case report吗<span class="quote">博学载医 2018-02-28 发表::<br>研究方向:Surgery;; 接收率:约25% 审稿时间:约2个月 投稿一周分配编辑,一周后找到审稿人,两周后审稿结束,decision两周,还是悲剧了。两个审稿人一位没意见,另一位小意见,但是还是被拒。后来仔细看发现编辑又审了一遍,但给的意见也是major comments and minor comments,感觉主编并不友好。</span><span class="quote">博学载医 2018-02-28 17:22:00 发表:<br>投稿一周分配编辑,一周后找到审稿人,两周后审稿结束,decision两周,还是悲剧了。两个审稿人一位没意见,另一位小意见,但是还是被拒。后来仔细看发现编辑又审了一遍,但给的意见也是major comments and minor comments,感觉主编并不友好。</span>, beContent=博学载医 2018-02-28 发表:: 研究方向:Surgery;; 接收率:约25% 审稿时间:约2个月 投稿一周分配编辑,一周后找到审稿人,两周后审稿结束,decision两周,还是悲剧了。两个审稿人一位没意见,另一位小意见,但是还是被拒。后来仔细看发现编辑又审了一遍,但给的意见也是major comments and minor comments,感觉主编并不友好。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6aca5170385, createdName=146d61a5m67暂无昵称, createdTime=Mon Aug 26 00:00:00 CST 2019, time=2019-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553307, encodeId=ed4355330eb8, content=版面费有吗?<span class="quote">156HyHB2616(暂无昵称) 2017-10-25 18:14:00 发表:<br>非常靠谱的杂志.没觉得有什么偏见...一审只用了10天.大修我改了1个多月.发过去.二审8天.小修.最后投过去.接受.稿费0.免费润色</span>, beContent=156HyHB2616(暂无昵称) 2017-10-25 18:14:00 发表: 非常靠谱的杂志.没觉得有什么偏见...一审只用了10天.大修我改了1个多月.发过去.二审8天.小修.最后投过去.接受.稿费0.免费润色, objectType=tool_impact_factor, channel=null, level=null, likeNumber=313, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20180212/IMG5A81B482ECD353220.jpg, createdBy=a0c02270586, createdName=121a3a14m76(暂无昵称), createdTime=Mon Mar 05 00:00:00 CST 2018, time=2018-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553109, encodeId=4a0055310909, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:投稿一周分配编辑,一周后找到审稿人,两周后审稿结束,decision两周,还是悲剧了。两个审稿人一位没意见,另一位小意见,但是还是被拒。后来仔细看发现编辑又审了一遍,但给的意见也是major comments and minor comments,感觉主编并不友好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=338, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5b551640992, createdName=博学载医, createdTime=Wed Feb 28 17:22:00 CST 2018, time=2018-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548580, encodeId=8fab54858072, content=审稿速度:1.0<br>经验分享:非常靠谱的杂志,没觉得有什么偏见。。。一审只用了10天,大修我改了1个多月,发过去,二审8天,小修,最后投过去,接受,稿费0,免费润色, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=346, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d5ef2181269, createdName=12072d6bm16(暂无昵称), createdTime=Wed Oct 25 18:14:00 CST 2017, time=2017-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=542236, encodeId=f2a154223664, content=从1.5分以下,现在接近2分,是好现象,这个杂志是你值得拥有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=332, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qiqi, createdTime=Fri Jul 14 18:48:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=516481, encodeId=4d5051648117, content=这个杂志真的是对中国人有偏见!5月19号投的,两个月后还没有选好审稿人,中间催稿两次都说叫等!等了四个月还是没有选好审稿人,更别说送外审了!最终撤稿,并投了一个三分多的杂志,顺利接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=456, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=10e649966, createdName=xbkld007, createdTime=Sun Nov 01 17:56:00 CST 2015, time=2015-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=503113, encodeId=ec125031132b, content=老板也是日本的知名教授,更是surgery today的associated editor, 一篇大作被老板要求投到这个杂志,很不情愿的投了,谁知最后被拒稿。老板对我说很SORRY, 很无奈。我之后转投近四分杂志,不到一月,直接接收。建议大家不要投这个杂志,不要自找没趣。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=479, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri May 23 14:01:00 CST 2014, time=2014-05-23, status=1, ipAttribution=)]
    2019-08-26 146d61a5m67暂无昵称

    接受case report吗博学载医 2018-02-28 发表::
    研究方向:Surgery;; 接收率:约25% 审稿时间:约2个月 投稿一周分配编辑,一周后找到审稿人,两周后审稿结束,decision两周,还是悲剧了。两个审稿人一位没意见,另一位小意见,但是还是被拒。后来仔细看发现编辑又审了一遍,但给的意见也是major comments and minor comments,感觉主编并不友好。
    博学载医 2018-02-28 17:22:00 发表:
    投稿一周分配编辑,一周后找到审稿人,两周后审稿结束,decision两周,还是悲剧了。两个审稿人一位没意见,另一位小意见,但是还是被拒。后来仔细看发现编辑又审了一遍,但给的意见也是major comments and minor comments,感觉主编并不友好。

    博学载医 2018-02-28 发表:: 研究方向:Surgery;; 接收率:约25% 审稿时间:约2个月 投稿一周分配编辑,一周后找到审稿人,两周后审稿结束,decision两周,还是悲剧了。两个审稿人一位没意见,另一位小意见,但是还是被拒。后来仔细看发现编辑又审了一遍,但给的意见也是major comments and minor comments,感觉主编并不友好。

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2090464, encodeId=053d2090464d6, content=体验不好,投了俩月多一直处于“Awaiting Reviewer Selection”,催稿无效,无奈撤稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erSFQMYTdHQEOAxjP3M9ByU7L9UO3NIuytMKlDZxgZIIhESgLN3yeoJWWxN0fSHVtNRM0lc7o1NGQ/132, createdBy=06932512300, createdName=今天也要好好学医, createdTime=Mon Sep 26 16:34:56 CST 2022, time=2022-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944931, encodeId=bfa794493124, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享:直肠癌相关,还是比较好中的,2021-01-06投的,2021-02-02一审意见回来,2021-02-21回稿,2021-03-02接收<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=336, replyNumber=1, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1b12571876, createdName=977872291_67259390, createdTime=Tue Mar 02 21:39:24 CST 2021, time=2021-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590992, encodeId=1685590992c6, content=open access能不选择吗?版面费多少钱 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9ff42573765, createdName=门童, createdTime=Sat May 16 00:00:00 CST 2020, time=2020-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575358, encodeId=eaed5e535807, content=接受case report吗<span class="quote">博学载医 2018-02-28 发表::<br>研究方向:Surgery;; 接收率:约25% 审稿时间:约2个月 投稿一周分配编辑,一周后找到审稿人,两周后审稿结束,decision两周,还是悲剧了。两个审稿人一位没意见,另一位小意见,但是还是被拒。后来仔细看发现编辑又审了一遍,但给的意见也是major comments and minor comments,感觉主编并不友好。</span><span class="quote">博学载医 2018-02-28 17:22:00 发表:<br>投稿一周分配编辑,一周后找到审稿人,两周后审稿结束,decision两周,还是悲剧了。两个审稿人一位没意见,另一位小意见,但是还是被拒。后来仔细看发现编辑又审了一遍,但给的意见也是major comments and minor comments,感觉主编并不友好。</span>, beContent=博学载医 2018-02-28 发表:: 研究方向:Surgery;; 接收率:约25% 审稿时间:约2个月 投稿一周分配编辑,一周后找到审稿人,两周后审稿结束,decision两周,还是悲剧了。两个审稿人一位没意见,另一位小意见,但是还是被拒。后来仔细看发现编辑又审了一遍,但给的意见也是major comments and minor comments,感觉主编并不友好。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6aca5170385, createdName=146d61a5m67暂无昵称, createdTime=Mon Aug 26 00:00:00 CST 2019, time=2019-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553307, encodeId=ed4355330eb8, content=版面费有吗?<span class="quote">156HyHB2616(暂无昵称) 2017-10-25 18:14:00 发表:<br>非常靠谱的杂志.没觉得有什么偏见...一审只用了10天.大修我改了1个多月.发过去.二审8天.小修.最后投过去.接受.稿费0.免费润色</span>, beContent=156HyHB2616(暂无昵称) 2017-10-25 18:14:00 发表: 非常靠谱的杂志.没觉得有什么偏见...一审只用了10天.大修我改了1个多月.发过去.二审8天.小修.最后投过去.接受.稿费0.免费润色, objectType=tool_impact_factor, channel=null, level=null, likeNumber=313, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20180212/IMG5A81B482ECD353220.jpg, createdBy=a0c02270586, createdName=121a3a14m76(暂无昵称), createdTime=Mon Mar 05 00:00:00 CST 2018, time=2018-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553109, encodeId=4a0055310909, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:投稿一周分配编辑,一周后找到审稿人,两周后审稿结束,decision两周,还是悲剧了。两个审稿人一位没意见,另一位小意见,但是还是被拒。后来仔细看发现编辑又审了一遍,但给的意见也是major comments and minor comments,感觉主编并不友好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=338, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5b551640992, createdName=博学载医, createdTime=Wed Feb 28 17:22:00 CST 2018, time=2018-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548580, encodeId=8fab54858072, content=审稿速度:1.0<br>经验分享:非常靠谱的杂志,没觉得有什么偏见。。。一审只用了10天,大修我改了1个多月,发过去,二审8天,小修,最后投过去,接受,稿费0,免费润色, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=346, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d5ef2181269, createdName=12072d6bm16(暂无昵称), createdTime=Wed Oct 25 18:14:00 CST 2017, time=2017-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=542236, encodeId=f2a154223664, content=从1.5分以下,现在接近2分,是好现象,这个杂志是你值得拥有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=332, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qiqi, createdTime=Fri Jul 14 18:48:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=516481, encodeId=4d5051648117, content=这个杂志真的是对中国人有偏见!5月19号投的,两个月后还没有选好审稿人,中间催稿两次都说叫等!等了四个月还是没有选好审稿人,更别说送外审了!最终撤稿,并投了一个三分多的杂志,顺利接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=456, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=10e649966, createdName=xbkld007, createdTime=Sun Nov 01 17:56:00 CST 2015, time=2015-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=503113, encodeId=ec125031132b, content=老板也是日本的知名教授,更是surgery today的associated editor, 一篇大作被老板要求投到这个杂志,很不情愿的投了,谁知最后被拒稿。老板对我说很SORRY, 很无奈。我之后转投近四分杂志,不到一月,直接接收。建议大家不要投这个杂志,不要自找没趣。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=479, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri May 23 14:01:00 CST 2014, time=2014-05-23, status=1, ipAttribution=)]
    2018-03-05 121a3a14m76(暂无昵称)

    版面费有吗?156HyHB2616(暂无昵称) 2017-10-25 18:14:00 发表:
    非常靠谱的杂志.没觉得有什么偏见...一审只用了10天.大修我改了1个多月.发过去.二审8天.小修.最后投过去.接受.稿费0.免费润色

    156HyHB2616(暂无昵称) 2017-10-25 18:14:00 发表: 非常靠谱的杂志.没觉得有什么偏见...一审只用了10天.大修我改了1个多月.发过去.二审8天.小修.最后投过去.接受.稿费0.免费润色

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=2090464, encodeId=053d2090464d6, content=体验不好,投了俩月多一直处于“Awaiting Reviewer Selection”,催稿无效,无奈撤稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erSFQMYTdHQEOAxjP3M9ByU7L9UO3NIuytMKlDZxgZIIhESgLN3yeoJWWxN0fSHVtNRM0lc7o1NGQ/132, createdBy=06932512300, createdName=今天也要好好学医, createdTime=Mon Sep 26 16:34:56 CST 2022, time=2022-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944931, encodeId=bfa794493124, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享:直肠癌相关,还是比较好中的,2021-01-06投的,2021-02-02一审意见回来,2021-02-21回稿,2021-03-02接收<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=336, replyNumber=1, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1b12571876, createdName=977872291_67259390, createdTime=Tue Mar 02 21:39:24 CST 2021, time=2021-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590992, encodeId=1685590992c6, content=open access能不选择吗?版面费多少钱 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9ff42573765, createdName=门童, createdTime=Sat May 16 00:00:00 CST 2020, time=2020-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575358, encodeId=eaed5e535807, content=接受case report吗<span class="quote">博学载医 2018-02-28 发表::<br>研究方向:Surgery;; 接收率:约25% 审稿时间:约2个月 投稿一周分配编辑,一周后找到审稿人,两周后审稿结束,decision两周,还是悲剧了。两个审稿人一位没意见,另一位小意见,但是还是被拒。后来仔细看发现编辑又审了一遍,但给的意见也是major comments and minor comments,感觉主编并不友好。</span><span class="quote">博学载医 2018-02-28 17:22:00 发表:<br>投稿一周分配编辑,一周后找到审稿人,两周后审稿结束,decision两周,还是悲剧了。两个审稿人一位没意见,另一位小意见,但是还是被拒。后来仔细看发现编辑又审了一遍,但给的意见也是major comments and minor comments,感觉主编并不友好。</span>, beContent=博学载医 2018-02-28 发表:: 研究方向:Surgery;; 接收率:约25% 审稿时间:约2个月 投稿一周分配编辑,一周后找到审稿人,两周后审稿结束,decision两周,还是悲剧了。两个审稿人一位没意见,另一位小意见,但是还是被拒。后来仔细看发现编辑又审了一遍,但给的意见也是major comments and minor comments,感觉主编并不友好。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6aca5170385, createdName=146d61a5m67暂无昵称, createdTime=Mon Aug 26 00:00:00 CST 2019, time=2019-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553307, encodeId=ed4355330eb8, content=版面费有吗?<span class="quote">156HyHB2616(暂无昵称) 2017-10-25 18:14:00 发表:<br>非常靠谱的杂志.没觉得有什么偏见...一审只用了10天.大修我改了1个多月.发过去.二审8天.小修.最后投过去.接受.稿费0.免费润色</span>, beContent=156HyHB2616(暂无昵称) 2017-10-25 18:14:00 发表: 非常靠谱的杂志.没觉得有什么偏见...一审只用了10天.大修我改了1个多月.发过去.二审8天.小修.最后投过去.接受.稿费0.免费润色, objectType=tool_impact_factor, channel=null, level=null, likeNumber=313, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20180212/IMG5A81B482ECD353220.jpg, createdBy=a0c02270586, createdName=121a3a14m76(暂无昵称), createdTime=Mon Mar 05 00:00:00 CST 2018, time=2018-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553109, encodeId=4a0055310909, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:投稿一周分配编辑,一周后找到审稿人,两周后审稿结束,decision两周,还是悲剧了。两个审稿人一位没意见,另一位小意见,但是还是被拒。后来仔细看发现编辑又审了一遍,但给的意见也是major comments and minor comments,感觉主编并不友好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=338, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5b551640992, createdName=博学载医, createdTime=Wed Feb 28 17:22:00 CST 2018, time=2018-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548580, encodeId=8fab54858072, content=审稿速度:1.0<br>经验分享:非常靠谱的杂志,没觉得有什么偏见。。。一审只用了10天,大修我改了1个多月,发过去,二审8天,小修,最后投过去,接受,稿费0,免费润色, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=346, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d5ef2181269, createdName=12072d6bm16(暂无昵称), createdTime=Wed Oct 25 18:14:00 CST 2017, time=2017-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=542236, encodeId=f2a154223664, content=从1.5分以下,现在接近2分,是好现象,这个杂志是你值得拥有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=332, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qiqi, createdTime=Fri Jul 14 18:48:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=516481, encodeId=4d5051648117, content=这个杂志真的是对中国人有偏见!5月19号投的,两个月后还没有选好审稿人,中间催稿两次都说叫等!等了四个月还是没有选好审稿人,更别说送外审了!最终撤稿,并投了一个三分多的杂志,顺利接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=456, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=10e649966, createdName=xbkld007, createdTime=Sun Nov 01 17:56:00 CST 2015, time=2015-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=503113, encodeId=ec125031132b, content=老板也是日本的知名教授,更是surgery today的associated editor, 一篇大作被老板要求投到这个杂志,很不情愿的投了,谁知最后被拒稿。老板对我说很SORRY, 很无奈。我之后转投近四分杂志,不到一月,直接接收。建议大家不要投这个杂志,不要自找没趣。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=479, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri May 23 14:01:00 CST 2014, time=2014-05-23, status=1, ipAttribution=)]
    2018-02-28 博学载医

    审稿速度:2.0 | 投稿命中率:25.0
    经验分享:投稿一周分配编辑,一周后找到审稿人,两周后审稿结束,decision两周,还是悲剧了。两个审稿人一位没意见,另一位小意见,但是还是被拒。后来仔细看发现编辑又审了一遍,但给的意见也是major comments and minor comments,感觉主编并不友好。

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=2090464, encodeId=053d2090464d6, content=体验不好,投了俩月多一直处于“Awaiting Reviewer Selection”,催稿无效,无奈撤稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erSFQMYTdHQEOAxjP3M9ByU7L9UO3NIuytMKlDZxgZIIhESgLN3yeoJWWxN0fSHVtNRM0lc7o1NGQ/132, createdBy=06932512300, createdName=今天也要好好学医, createdTime=Mon Sep 26 16:34:56 CST 2022, time=2022-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944931, encodeId=bfa794493124, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享:直肠癌相关,还是比较好中的,2021-01-06投的,2021-02-02一审意见回来,2021-02-21回稿,2021-03-02接收<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=336, replyNumber=1, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1b12571876, createdName=977872291_67259390, createdTime=Tue Mar 02 21:39:24 CST 2021, time=2021-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590992, encodeId=1685590992c6, content=open access能不选择吗?版面费多少钱 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9ff42573765, createdName=门童, createdTime=Sat May 16 00:00:00 CST 2020, time=2020-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575358, encodeId=eaed5e535807, content=接受case report吗<span class="quote">博学载医 2018-02-28 发表::<br>研究方向:Surgery;; 接收率:约25% 审稿时间:约2个月 投稿一周分配编辑,一周后找到审稿人,两周后审稿结束,decision两周,还是悲剧了。两个审稿人一位没意见,另一位小意见,但是还是被拒。后来仔细看发现编辑又审了一遍,但给的意见也是major comments and minor comments,感觉主编并不友好。</span><span class="quote">博学载医 2018-02-28 17:22:00 发表:<br>投稿一周分配编辑,一周后找到审稿人,两周后审稿结束,decision两周,还是悲剧了。两个审稿人一位没意见,另一位小意见,但是还是被拒。后来仔细看发现编辑又审了一遍,但给的意见也是major comments and minor comments,感觉主编并不友好。</span>, beContent=博学载医 2018-02-28 发表:: 研究方向:Surgery;; 接收率:约25% 审稿时间:约2个月 投稿一周分配编辑,一周后找到审稿人,两周后审稿结束,decision两周,还是悲剧了。两个审稿人一位没意见,另一位小意见,但是还是被拒。后来仔细看发现编辑又审了一遍,但给的意见也是major comments and minor comments,感觉主编并不友好。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6aca5170385, createdName=146d61a5m67暂无昵称, createdTime=Mon Aug 26 00:00:00 CST 2019, time=2019-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553307, encodeId=ed4355330eb8, content=版面费有吗?<span class="quote">156HyHB2616(暂无昵称) 2017-10-25 18:14:00 发表:<br>非常靠谱的杂志.没觉得有什么偏见...一审只用了10天.大修我改了1个多月.发过去.二审8天.小修.最后投过去.接受.稿费0.免费润色</span>, beContent=156HyHB2616(暂无昵称) 2017-10-25 18:14:00 发表: 非常靠谱的杂志.没觉得有什么偏见...一审只用了10天.大修我改了1个多月.发过去.二审8天.小修.最后投过去.接受.稿费0.免费润色, objectType=tool_impact_factor, channel=null, level=null, likeNumber=313, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20180212/IMG5A81B482ECD353220.jpg, createdBy=a0c02270586, createdName=121a3a14m76(暂无昵称), createdTime=Mon Mar 05 00:00:00 CST 2018, time=2018-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553109, encodeId=4a0055310909, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:投稿一周分配编辑,一周后找到审稿人,两周后审稿结束,decision两周,还是悲剧了。两个审稿人一位没意见,另一位小意见,但是还是被拒。后来仔细看发现编辑又审了一遍,但给的意见也是major comments and minor comments,感觉主编并不友好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=338, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5b551640992, createdName=博学载医, createdTime=Wed Feb 28 17:22:00 CST 2018, time=2018-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548580, encodeId=8fab54858072, content=审稿速度:1.0<br>经验分享:非常靠谱的杂志,没觉得有什么偏见。。。一审只用了10天,大修我改了1个多月,发过去,二审8天,小修,最后投过去,接受,稿费0,免费润色, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=346, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d5ef2181269, createdName=12072d6bm16(暂无昵称), createdTime=Wed Oct 25 18:14:00 CST 2017, time=2017-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=542236, encodeId=f2a154223664, content=从1.5分以下,现在接近2分,是好现象,这个杂志是你值得拥有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=332, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qiqi, createdTime=Fri Jul 14 18:48:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=516481, encodeId=4d5051648117, content=这个杂志真的是对中国人有偏见!5月19号投的,两个月后还没有选好审稿人,中间催稿两次都说叫等!等了四个月还是没有选好审稿人,更别说送外审了!最终撤稿,并投了一个三分多的杂志,顺利接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=456, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=10e649966, createdName=xbkld007, createdTime=Sun Nov 01 17:56:00 CST 2015, time=2015-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=503113, encodeId=ec125031132b, content=老板也是日本的知名教授,更是surgery today的associated editor, 一篇大作被老板要求投到这个杂志,很不情愿的投了,谁知最后被拒稿。老板对我说很SORRY, 很无奈。我之后转投近四分杂志,不到一月,直接接收。建议大家不要投这个杂志,不要自找没趣。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=479, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri May 23 14:01:00 CST 2014, time=2014-05-23, status=1, ipAttribution=)]
    2017-10-25 12072d6bm16(暂无昵称)

    审稿速度:1.0
    经验分享:非常靠谱的杂志,没觉得有什么偏见。。。一审只用了10天,大修我改了1个多月,发过去,二审8天,小修,最后投过去,接受,稿费0,免费润色

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=2090464, encodeId=053d2090464d6, content=体验不好,投了俩月多一直处于“Awaiting Reviewer Selection”,催稿无效,无奈撤稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erSFQMYTdHQEOAxjP3M9ByU7L9UO3NIuytMKlDZxgZIIhESgLN3yeoJWWxN0fSHVtNRM0lc7o1NGQ/132, createdBy=06932512300, createdName=今天也要好好学医, createdTime=Mon Sep 26 16:34:56 CST 2022, time=2022-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944931, encodeId=bfa794493124, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享:直肠癌相关,还是比较好中的,2021-01-06投的,2021-02-02一审意见回来,2021-02-21回稿,2021-03-02接收<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=336, replyNumber=1, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1b12571876, createdName=977872291_67259390, createdTime=Tue Mar 02 21:39:24 CST 2021, time=2021-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590992, encodeId=1685590992c6, content=open access能不选择吗?版面费多少钱 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9ff42573765, createdName=门童, createdTime=Sat May 16 00:00:00 CST 2020, time=2020-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575358, encodeId=eaed5e535807, content=接受case report吗<span class="quote">博学载医 2018-02-28 发表::<br>研究方向:Surgery;; 接收率:约25% 审稿时间:约2个月 投稿一周分配编辑,一周后找到审稿人,两周后审稿结束,decision两周,还是悲剧了。两个审稿人一位没意见,另一位小意见,但是还是被拒。后来仔细看发现编辑又审了一遍,但给的意见也是major comments and minor comments,感觉主编并不友好。</span><span class="quote">博学载医 2018-02-28 17:22:00 发表:<br>投稿一周分配编辑,一周后找到审稿人,两周后审稿结束,decision两周,还是悲剧了。两个审稿人一位没意见,另一位小意见,但是还是被拒。后来仔细看发现编辑又审了一遍,但给的意见也是major comments and minor comments,感觉主编并不友好。</span>, beContent=博学载医 2018-02-28 发表:: 研究方向:Surgery;; 接收率:约25% 审稿时间:约2个月 投稿一周分配编辑,一周后找到审稿人,两周后审稿结束,decision两周,还是悲剧了。两个审稿人一位没意见,另一位小意见,但是还是被拒。后来仔细看发现编辑又审了一遍,但给的意见也是major comments and minor comments,感觉主编并不友好。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6aca5170385, createdName=146d61a5m67暂无昵称, createdTime=Mon Aug 26 00:00:00 CST 2019, time=2019-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553307, encodeId=ed4355330eb8, content=版面费有吗?<span class="quote">156HyHB2616(暂无昵称) 2017-10-25 18:14:00 发表:<br>非常靠谱的杂志.没觉得有什么偏见...一审只用了10天.大修我改了1个多月.发过去.二审8天.小修.最后投过去.接受.稿费0.免费润色</span>, beContent=156HyHB2616(暂无昵称) 2017-10-25 18:14:00 发表: 非常靠谱的杂志.没觉得有什么偏见...一审只用了10天.大修我改了1个多月.发过去.二审8天.小修.最后投过去.接受.稿费0.免费润色, objectType=tool_impact_factor, channel=null, level=null, likeNumber=313, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20180212/IMG5A81B482ECD353220.jpg, createdBy=a0c02270586, createdName=121a3a14m76(暂无昵称), createdTime=Mon Mar 05 00:00:00 CST 2018, time=2018-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553109, encodeId=4a0055310909, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:投稿一周分配编辑,一周后找到审稿人,两周后审稿结束,decision两周,还是悲剧了。两个审稿人一位没意见,另一位小意见,但是还是被拒。后来仔细看发现编辑又审了一遍,但给的意见也是major comments and minor comments,感觉主编并不友好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=338, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5b551640992, createdName=博学载医, createdTime=Wed Feb 28 17:22:00 CST 2018, time=2018-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548580, encodeId=8fab54858072, content=审稿速度:1.0<br>经验分享:非常靠谱的杂志,没觉得有什么偏见。。。一审只用了10天,大修我改了1个多月,发过去,二审8天,小修,最后投过去,接受,稿费0,免费润色, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=346, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d5ef2181269, createdName=12072d6bm16(暂无昵称), createdTime=Wed Oct 25 18:14:00 CST 2017, time=2017-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=542236, encodeId=f2a154223664, content=从1.5分以下,现在接近2分,是好现象,这个杂志是你值得拥有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=332, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qiqi, createdTime=Fri Jul 14 18:48:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=516481, encodeId=4d5051648117, content=这个杂志真的是对中国人有偏见!5月19号投的,两个月后还没有选好审稿人,中间催稿两次都说叫等!等了四个月还是没有选好审稿人,更别说送外审了!最终撤稿,并投了一个三分多的杂志,顺利接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=456, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=10e649966, createdName=xbkld007, createdTime=Sun Nov 01 17:56:00 CST 2015, time=2015-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=503113, encodeId=ec125031132b, content=老板也是日本的知名教授,更是surgery today的associated editor, 一篇大作被老板要求投到这个杂志,很不情愿的投了,谁知最后被拒稿。老板对我说很SORRY, 很无奈。我之后转投近四分杂志,不到一月,直接接收。建议大家不要投这个杂志,不要自找没趣。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=479, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri May 23 14:01:00 CST 2014, time=2014-05-23, status=1, ipAttribution=)]
    2017-07-14 qiqi

    从1.5分以下,现在接近2分,是好现象,这个杂志是你值得拥有

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=2090464, encodeId=053d2090464d6, content=体验不好,投了俩月多一直处于“Awaiting Reviewer Selection”,催稿无效,无奈撤稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erSFQMYTdHQEOAxjP3M9ByU7L9UO3NIuytMKlDZxgZIIhESgLN3yeoJWWxN0fSHVtNRM0lc7o1NGQ/132, createdBy=06932512300, createdName=今天也要好好学医, createdTime=Mon Sep 26 16:34:56 CST 2022, time=2022-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944931, encodeId=bfa794493124, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享:直肠癌相关,还是比较好中的,2021-01-06投的,2021-02-02一审意见回来,2021-02-21回稿,2021-03-02接收<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=336, replyNumber=1, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1b12571876, createdName=977872291_67259390, createdTime=Tue Mar 02 21:39:24 CST 2021, time=2021-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590992, encodeId=1685590992c6, content=open access能不选择吗?版面费多少钱 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9ff42573765, createdName=门童, createdTime=Sat May 16 00:00:00 CST 2020, time=2020-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575358, encodeId=eaed5e535807, content=接受case report吗<span class="quote">博学载医 2018-02-28 发表::<br>研究方向:Surgery;; 接收率:约25% 审稿时间:约2个月 投稿一周分配编辑,一周后找到审稿人,两周后审稿结束,decision两周,还是悲剧了。两个审稿人一位没意见,另一位小意见,但是还是被拒。后来仔细看发现编辑又审了一遍,但给的意见也是major comments and minor comments,感觉主编并不友好。</span><span class="quote">博学载医 2018-02-28 17:22:00 发表:<br>投稿一周分配编辑,一周后找到审稿人,两周后审稿结束,decision两周,还是悲剧了。两个审稿人一位没意见,另一位小意见,但是还是被拒。后来仔细看发现编辑又审了一遍,但给的意见也是major comments and minor comments,感觉主编并不友好。</span>, beContent=博学载医 2018-02-28 发表:: 研究方向:Surgery;; 接收率:约25% 审稿时间:约2个月 投稿一周分配编辑,一周后找到审稿人,两周后审稿结束,decision两周,还是悲剧了。两个审稿人一位没意见,另一位小意见,但是还是被拒。后来仔细看发现编辑又审了一遍,但给的意见也是major comments and minor comments,感觉主编并不友好。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6aca5170385, createdName=146d61a5m67暂无昵称, createdTime=Mon Aug 26 00:00:00 CST 2019, time=2019-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553307, encodeId=ed4355330eb8, content=版面费有吗?<span class="quote">156HyHB2616(暂无昵称) 2017-10-25 18:14:00 发表:<br>非常靠谱的杂志.没觉得有什么偏见...一审只用了10天.大修我改了1个多月.发过去.二审8天.小修.最后投过去.接受.稿费0.免费润色</span>, beContent=156HyHB2616(暂无昵称) 2017-10-25 18:14:00 发表: 非常靠谱的杂志.没觉得有什么偏见...一审只用了10天.大修我改了1个多月.发过去.二审8天.小修.最后投过去.接受.稿费0.免费润色, objectType=tool_impact_factor, channel=null, level=null, likeNumber=313, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20180212/IMG5A81B482ECD353220.jpg, createdBy=a0c02270586, createdName=121a3a14m76(暂无昵称), createdTime=Mon Mar 05 00:00:00 CST 2018, time=2018-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553109, encodeId=4a0055310909, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:投稿一周分配编辑,一周后找到审稿人,两周后审稿结束,decision两周,还是悲剧了。两个审稿人一位没意见,另一位小意见,但是还是被拒。后来仔细看发现编辑又审了一遍,但给的意见也是major comments and minor comments,感觉主编并不友好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=338, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5b551640992, createdName=博学载医, createdTime=Wed Feb 28 17:22:00 CST 2018, time=2018-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548580, encodeId=8fab54858072, content=审稿速度:1.0<br>经验分享:非常靠谱的杂志,没觉得有什么偏见。。。一审只用了10天,大修我改了1个多月,发过去,二审8天,小修,最后投过去,接受,稿费0,免费润色, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=346, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d5ef2181269, createdName=12072d6bm16(暂无昵称), createdTime=Wed Oct 25 18:14:00 CST 2017, time=2017-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=542236, encodeId=f2a154223664, content=从1.5分以下,现在接近2分,是好现象,这个杂志是你值得拥有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=332, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qiqi, createdTime=Fri Jul 14 18:48:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=516481, encodeId=4d5051648117, content=这个杂志真的是对中国人有偏见!5月19号投的,两个月后还没有选好审稿人,中间催稿两次都说叫等!等了四个月还是没有选好审稿人,更别说送外审了!最终撤稿,并投了一个三分多的杂志,顺利接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=456, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=10e649966, createdName=xbkld007, createdTime=Sun Nov 01 17:56:00 CST 2015, time=2015-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=503113, encodeId=ec125031132b, content=老板也是日本的知名教授,更是surgery today的associated editor, 一篇大作被老板要求投到这个杂志,很不情愿的投了,谁知最后被拒稿。老板对我说很SORRY, 很无奈。我之后转投近四分杂志,不到一月,直接接收。建议大家不要投这个杂志,不要自找没趣。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=479, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri May 23 14:01:00 CST 2014, time=2014-05-23, status=1, ipAttribution=)]
    2015-11-01 xbkld007

    这个杂志真的是对中国人有偏见!5月19号投的,两个月后还没有选好审稿人,中间催稿两次都说叫等!等了四个月还是没有选好审稿人,更别说送外审了!最终撤稿,并投了一个三分多的杂志,顺利接受。

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=2090464, encodeId=053d2090464d6, content=体验不好,投了俩月多一直处于“Awaiting Reviewer Selection”,催稿无效,无奈撤稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83erSFQMYTdHQEOAxjP3M9ByU7L9UO3NIuytMKlDZxgZIIhESgLN3yeoJWWxN0fSHVtNRM0lc7o1NGQ/132, createdBy=06932512300, createdName=今天也要好好学医, createdTime=Mon Sep 26 16:34:56 CST 2022, time=2022-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944931, encodeId=bfa794493124, content=审稿速度:1.0 | 投稿命中率:75.0<br>经验分享:直肠癌相关,还是比较好中的,2021-01-06投的,2021-02-02一审意见回来,2021-02-21回稿,2021-03-02接收<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a>, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=336, replyNumber=1, topicName=null, topicId=null, topicList=[TopicDto(id=82769, encryptionId=aa0582e6946, topicName=肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a1b12571876, createdName=977872291_67259390, createdTime=Tue Mar 02 21:39:24 CST 2021, time=2021-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590992, encodeId=1685590992c6, content=open access能不选择吗?版面费多少钱 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9ff42573765, createdName=门童, createdTime=Sat May 16 00:00:00 CST 2020, time=2020-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575358, encodeId=eaed5e535807, content=接受case report吗<span class="quote">博学载医 2018-02-28 发表::<br>研究方向:Surgery;; 接收率:约25% 审稿时间:约2个月 投稿一周分配编辑,一周后找到审稿人,两周后审稿结束,decision两周,还是悲剧了。两个审稿人一位没意见,另一位小意见,但是还是被拒。后来仔细看发现编辑又审了一遍,但给的意见也是major comments and minor comments,感觉主编并不友好。</span><span class="quote">博学载医 2018-02-28 17:22:00 发表:<br>投稿一周分配编辑,一周后找到审稿人,两周后审稿结束,decision两周,还是悲剧了。两个审稿人一位没意见,另一位小意见,但是还是被拒。后来仔细看发现编辑又审了一遍,但给的意见也是major comments and minor comments,感觉主编并不友好。</span>, beContent=博学载医 2018-02-28 发表:: 研究方向:Surgery;; 接收率:约25% 审稿时间:约2个月 投稿一周分配编辑,一周后找到审稿人,两周后审稿结束,decision两周,还是悲剧了。两个审稿人一位没意见,另一位小意见,但是还是被拒。后来仔细看发现编辑又审了一遍,但给的意见也是major comments and minor comments,感觉主编并不友好。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6aca5170385, createdName=146d61a5m67暂无昵称, createdTime=Mon Aug 26 00:00:00 CST 2019, time=2019-08-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553307, encodeId=ed4355330eb8, content=版面费有吗?<span class="quote">156HyHB2616(暂无昵称) 2017-10-25 18:14:00 发表:<br>非常靠谱的杂志.没觉得有什么偏见...一审只用了10天.大修我改了1个多月.发过去.二审8天.小修.最后投过去.接受.稿费0.免费润色</span>, beContent=156HyHB2616(暂无昵称) 2017-10-25 18:14:00 发表: 非常靠谱的杂志.没觉得有什么偏见...一审只用了10天.大修我改了1个多月.发过去.二审8天.小修.最后投过去.接受.稿费0.免费润色, objectType=tool_impact_factor, channel=null, level=null, likeNumber=313, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20180212/IMG5A81B482ECD353220.jpg, createdBy=a0c02270586, createdName=121a3a14m76(暂无昵称), createdTime=Mon Mar 05 00:00:00 CST 2018, time=2018-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553109, encodeId=4a0055310909, content=审稿速度:2.0 | 投稿命中率:25.0<br>经验分享:投稿一周分配编辑,一周后找到审稿人,两周后审稿结束,decision两周,还是悲剧了。两个审稿人一位没意见,另一位小意见,但是还是被拒。后来仔细看发现编辑又审了一遍,但给的意见也是major comments and minor comments,感觉主编并不友好。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=338, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=5b551640992, createdName=博学载医, createdTime=Wed Feb 28 17:22:00 CST 2018, time=2018-02-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=548580, encodeId=8fab54858072, content=审稿速度:1.0<br>经验分享:非常靠谱的杂志,没觉得有什么偏见。。。一审只用了10天,大修我改了1个多月,发过去,二审8天,小修,最后投过去,接受,稿费0,免费润色, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=346, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d5ef2181269, createdName=12072d6bm16(暂无昵称), createdTime=Wed Oct 25 18:14:00 CST 2017, time=2017-10-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=542236, encodeId=f2a154223664, content=从1.5分以下,现在接近2分,是好现象,这个杂志是你值得拥有, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=332, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qiqi, createdTime=Fri Jul 14 18:48:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=516481, encodeId=4d5051648117, content=这个杂志真的是对中国人有偏见!5月19号投的,两个月后还没有选好审稿人,中间催稿两次都说叫等!等了四个月还是没有选好审稿人,更别说送外审了!最终撤稿,并投了一个三分多的杂志,顺利接受。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=456, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=10e649966, createdName=xbkld007, createdTime=Sun Nov 01 17:56:00 CST 2015, time=2015-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=503113, encodeId=ec125031132b, content=老板也是日本的知名教授,更是surgery today的associated editor, 一篇大作被老板要求投到这个杂志,很不情愿的投了,谁知最后被拒稿。老板对我说很SORRY, 很无奈。我之后转投近四分杂志,不到一月,直接接收。建议大家不要投这个杂志,不要自找没趣。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=479, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri May 23 14:01:00 CST 2014, time=2014-05-23, status=1, ipAttribution=)]
    2014-05-23 匿名用户

    老板也是日本的知名教授,更是surgery today的associated editor, 一篇大作被老板要求投到这个杂志,很不情愿的投了,谁知最后被拒稿。老板对我说很SORRY, 很无奈。我之后转投近四分杂志,不到一月,直接接收。建议大家不要投这个杂志,不要自找没趣。

    0

共21条页码: 1/3页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分